β-Galactosidase CRISPR Activation Plasmid

CAT:
952-B2014904
Size:
10 µg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
β-Galactosidase CRISPR Activation Plasmid - image 1
β-Galactosidase CRISPR Activation Plasmid - image 2
Thumbnail 1
Thumbnail 2

β-Galactosidase CRISPR Activation Plasmid

  • Description:

    β-Galactosidase CRISPR Activation Plasmid_x000D_ Catalog number: B2014904_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 10 µg_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Liquid_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: -20°C_x000D_ Keywords: β-Galactosidase CRISPR Activation Plasmid_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Watzlawick H, Altenbuchner J. Multiple integration of the gene ganA into the Bacillus subtilis chromosome for enhanced β-galactosidase production using the CRISPR/Cas9 system AMB Express. 2019 Sep 30;9(1):158._x000D_ 2: Szentes S, Zsibrita N, Koncz M, Zsigmond E, Salamon P, Pletl Z, Kiss A. I-Block: a simple Escherichia coli-based assay for studying sequence-specific DNA binding of proteins Nucleic Acids Res. 2020 Mar 18;48(5):e28._x000D_ 3: Manica A, Zebec Z, Teichmann D, Schleper C. In vivo activity of CRISPR-mediated virus defence in a hyperthermophilic archaeon Mol Microbiol. 2011 Apr;80(2):481-91._x000D_ 4: Lau CH, Bolt EL. Integration of diverse DNA substrates by a casposase can be targeted to R-loops in vitro by its fusion to Cas9 Biosci Rep. 2021 Jan 29;41(1):BSR20203595._x000D_ 5: Watzlawick H, Altenbuchner J. Multiple integration of the gene ganA into the Bacillus subtilis chromosome for enhanced β-galactosidase production using the CRISPR/Cas9 system AMB Express. 2019 Sep 30;9(1):158._x000D_ 6: Tang Z, Hegde S, Zhao J, Zhu S, Johnson KA, Lorson CL, Wang J. CRISPR-Mediated Enzyme Fragment Complementation Assay for Quantification of the Stability of Splice Isoforms Chembiochem. 2022 May 4;23(9):e202200012._x000D_ 7: Liu S, Feng Y, Huang Y, Jiang X, Tang C, Tang F, Zeng C, Liu L. A GM1 gangliosidosis mutant mouse model exhibits activated microglia and disturbed autophagy Exp Biol Med (Maywood). 2021 Jun;246(11):1330-1341._x000D_ 8: Kaneski CR, Hanover JA, Schueler Hoffman UH. Generation of GLA-knockout human embryonic stem cell lines to model peripheral neuropathy in Fabry disease Mol Genet Metab Rep. 2022 Aug 27;33:100914._x000D_ 9: de Malmanche H, Marcellin E, Reid S. Knockout of Sf-Caspase-1 generates apoptosis-resistant Sf9 cell lines: Implications for baculovirus expression Biotechnol J. 2022 Jul;17(7):e2100532._x000D_ 10: Zhao R, Kaakati R, Liu X, Xu L, Lee AK, Bachelder R, Li CY, Hollenbeck ST. CRISPR/Cas9-Mediated BRCA1 Knockdown Adipose Stem Cells Promote Breast Cancer Progression Plast Reconstr Surg. 2019 Mar;143(3):747-756. _x000D_ _x000D_ Products Related to β-Galactosidase CRISPR Activation Plasmid can be found at DNA
  • Short Description:

    Catalog Number: B2014904 (10 µg)_x000D_ β-Galactosidase CRISPR Activation Plasmid is a high quality β-Galactosidase CRISPR Activation Plasmid. This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height :

    0.5